| Neutrophils: important contributors to tumor progression and metastasis A Swierczak, KA Mouchemore, JA Hamilton, RL Anderson Cancer and Metastasis Reviews, 1-17, 2015 | 240 | 2015 |
| Neutrophils, G‐CSF and their contribution to breast cancer metastasis KA Mouchemore, RL Anderson, JA Hamilton The FEBS Journal, 2017 | 130 | 2017 |
| CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways KA Mouchemore, FJ Pixley Critical reviews in clinical laboratory sciences 49 (2), 49-61, 2012 | 68 | 2012 |
| Specific inhibition of PI3K p110δ inhibits CSF‐1‐induced macrophage spreading and invasive capacity KA Mouchemore, NG Sampaio, MW Murrey, E Richard Stanley, ... FEBS Journal, 2013 | 43 | 2013 |
| Mammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis RKH Yip, JS Rimes, BD Capaldo, F Vaillant, KA Mouchemore, B Pal, ... Nature Communications 12 (1), 1-17, 2021 | 39 | 2021 |
| The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression B Yeo, AD Redfern, KA Mouchemore, JA Hamilton, RL Anderson Clinical & experimental metastasis, 1-13, 2018 | 31 | 2018 |
| Src family kinase expression and subcellular localization in macrophages: implications for their role in CSF-1-induced macrophage migration AR Dwyer, KA Mouchemore, JH Steer, AJ Sunderland, NG Sampaio, ... Journal of leukocyte biology, jlb. 2A0815-344RR, 2016 | 25 | 2016 |
| Immunomodulatory effects of G-CSF in cancer: Therapeutic implications KA Mouchemore, RL Anderson Seminars in Immunology, 101512, 2021 | 24 | 2021 |
| MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms LH Chi, RSN Cross, RP Redvers, M Davis, S Hediyeh-Zadeh, ... Oncogenesis 11 (1), 1-12, 2022 | 11 | 2022 |
| Neutrophils as therapeutic targets in metastatic breast cancer K Mouchemore, A Swierczak, N Haynes, J Hamilton, R Anderson EUROPEAN JOURNAL OF IMMUNOLOGY 46, 211-211, 2016 | | 2016 |
